MET and lung adenocarcinoma: To determine whether the MET-induced EGFR inhibition observed in lung tumors from EGFR/MET mice was clinically relevant, we performed a correlation analysis of pEGFR and pMET expression in a TCGA cohort of patients with lung adenocarcinoma [9].